NCT06957717

Brief Summary

Introduction: The prevalence of anemia among adolescent girls in Indonesia is still quite high. According to the Indonesian Health Survey (IHS) in 2023, it was 18% and is still a national problem. Long-term supplementation of blood supplement tablets (TTD) as an effort made by the government to prevent/overcome anemia has caused side effects, namely dysbiosis by pathogenic bacteria. Giving cow's milk kefir containing various probiotics can overcome the side effects of supplementation, and its metabolites accelerate iron absorption so that iron status in the blood increases and ultimately restores anemia in adolescent girls. Method: It's research is an experimental study, with a Randomized Controlled Trial (RCT) design, pre-posttest design, involving research subjects of adolescent girls (15-18 years) with mild and moderate anemia, at SMKN 1, 2, and 3 Kasihan, Bantul Regency, Yogyakarta as many as 80 students. Subjects were divided into 2 groups, namely group 1 (treatment group), which was given 120 ml of cow's milk kefir every day and TTD 1 grain/week, and group 2 (control group), which was given 120 ml of cow's milk every day and TTD 1 grain/week. The duration of administration was 2 months. The study outcomes were Short Chain Fatty Acid (SCFA) levels in feces by Gas Chromatography-Mass Spectrometry (GC-MS) method, hemoglobin by Hematology Analyser method, and serum ferritin by Ferritin ELISA measured at the beginning and end of the study. Statistical analysis included univariate, bivariate, and multivariate analysis. Clinical analysis was also conducted to estimate the effect size of the treatment

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 4, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

May 4, 2025

Status Verified

May 1, 2025

Enrollment Period

7 months

First QC Date

April 25, 2025

Last Update Submit

May 2, 2025

Conditions

Keywords

KefirShort Chain Fatty AcidHemoglobinFerritinIron Deficiency Anemia

Outcome Measures

Primary Outcomes (3)

  • Short Chain Fatty Acid

    SCFA (acetate, propionate, and butyrate) levels in fresh feces of adolescent girls, using the GC-MS (Gas Chromatography-Mass Spectrometry) Method, were measured before (0 months) and after the intervention (2 months), using a ratio scale. The examination procedure included collecting feces in the field according to the procedure at https://drive.google.com/drive/folders/1uXklwFuC-1rnQ1Anim86b7-9pqLSheIz. Fresh feces samples were collected immediately, by storing them in a cool box (to maintain the quality of feces so that it remains stable during storage and transportation, and avoid the maturation process that can affect the results of lab tests, so that the results of the lab analysis carried out can be accurate and valid), and then immediately taken to the laboratory to quantify each of the short chain fatty acids (SCFA) in the sample.

    2 months after intervention

  • hemoglobin

    Adolescent girls' hemoglobin values in the blood taken from the median cubital vein, using the hematology analyzer method (unit g/dl), were measured before (0 months) and after the intervention (2 months), using a ratio scale.

    2 months after intervention

  • Ferritin

    Ferritin content in the blood of adolescent girls taken from the median cubital vein, using the Ferritin ELISA method (unit µg/L), was measured before (0 months) and after the intervention (2 months), using a ratio scale

    2 months after intervention

Secondary Outcomes (4)

  • Nutrient intake

    2 months after intervention

  • Nutritional status of adolescent girls (body mass index / age)

    2 months after intervention

  • Menstrual cycle and duration of adolescent girls

    2 months after intervention

  • Diarrhea

    2 months after intervention

Study Arms (2)

intervention group

ACTIVE COMPARATOR

Fresh cow's milk drink pasteurized at 72 °C, and fermented by kefir grain (5%) for 24 hours at 25 °C, then filtered to produce cow's milk kefir, and stored at 4 °C for 24 hours before drinking, given as 1 bottle/day of 120 ml + 10% liquid sugar for 2 months.

Combination Product: cow's milk kefir

control group

PLACEBO COMPARATOR

Fresh cow's milk drink pasteurized at 72 °C, without fermentation, given 1 bottle/day of 132 ml for 2 months

Combination Product: pasteurized cow's milk

Interventions

cow's milk kefirCOMBINATION_PRODUCT

group given cow's milk kefir and blood supplement tablets (TTD)

Also known as: intervention group
intervention group
pasteurized cow's milkCOMBINATION_PRODUCT

group given pasteurized cow's milk and blood supplement tablets (TTD)

Also known as: control group
control group

Eligibility Criteria

Age15 Years - 18 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAdolescent girls as future mothers
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescent girls aged 15-18 years
  • Have a mild and moderate degree of anemia (Hb 8-11.9 g/dl)
  • Have a normal menstrual cycle and duration

You may not qualify if:

  • Suffering from thalassemia, hemosiderosis, blood cancer, and malaria, based on the doctor's diagnosis in the last 3 months
  • Taking supplements other than TTD
  • Taking antibiotics in the last 3 months
  • Suffering from lactose intolerance through interviews

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gadjah Mada University

Yogyakarta, Special Region of Yogyakarta, 55281, Indonesia

Location

MeSH Terms

Conditions

Anemia, Iron-Deficiency

Interventions

MilkControl Groups

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

BeveragesDiet, Food, and NutritionPhysiological PhenomenaDairy ProductsFoodFood and BeveragesEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
In addition to participants, service providers, and outcomes assessors, it is also disguised from statisticians or data processors so that the data obtained does not become biased
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Its research is an experimental study, with a Randomized Controlled Trial (RCT) design, pre-posttest design, involving research subjects of adolescent girls (15-18 years) with mild and moderate anemia, at SMKN 1, 2, and 3 Kasihan, Bantul Regency, Yogyakarta, as many as 80 students. Subjects were divided into 2 groups, namely group 1 (treatment group), which was given 120 ml of cow's milk kefir every day and TTD 1 grain/week, and group 2 (control group), which was given 120 ml of cow's milk every day and TTD 1 grain/week. The duration of administration was 2 months. The study outcomes were Short Chain Fatty Acid (SCFA) levels in feces by Gas Chromatography-Mass Spectrometry (GC-MS) method, hemoglobin by Hematology Analyser method, and serum ferritin by Ferritin ELISA measured at the beginning and end of the study. Statistical analysis included univariate, bivariate, and multivariate analysis. Clinical analysis was also conducted to estimate the effect size of the treatment
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
doctoral students of the faculty of medicine, public health and nursing, Gadjah Mada University

Study Record Dates

First Submitted

April 25, 2025

First Posted

May 4, 2025

Study Start

May 1, 2025

Primary Completion

December 1, 2025

Study Completion

May 1, 2026

Last Updated

May 4, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

IPD data will be shared, but in the form of coding.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
IPD can be obtained after the dissertation is registered at the Universitas Gadjah Mada Library or the Faculty of Medicine, Public Health, and Nursing Library
Access Criteria
Only investigator
More information

Locations